Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

Human CCR4 Monoclonal Antibody

Produktgrößen
1 mg
£486,00
YR0126-1MG
5 mg
£1355,00
YR0126-5MG
20 mg
£4401,00
YR0126-20MG
Über dieses Produkt
SKU:
YR0126
Zusätzliche Namen:
CC-CKR-4|CD194|ChemR13|CKR4|CMKBR4|HGCN:14099|K5-5
Anwendung:
Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Klonalität:
Monoclonal
Weitere Details:
Mogamulizumab is a humanized monoclonal antibody (mAb) directed against CC chemokine receptor 4 (CCR4) for the treatment of Mycosis Fungoides (MF) and Sezary Syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma. Cutaneous T-cell lymphomas occur when certain white blood cells, called T cells, become cancerous; these cancers typically affect the skin, causing various types of skin lesions.Mogamulizumab selectively binds to and inhibits the activity of CCR4, which may block CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, as well as chemokine-mediated angiogenesis. Additionally, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and certain types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells. In addition to directly targeting malignant T cells expressing CCR4, mogamulizumab depletes Treg cells, an important therapeutic target in many human cancers because of their role in suppressing host antitumor immunity.
Formulierung:
Purified from cell culture supernatant in an animal-free facility
Immunogen:
Human CCR4
Isotyp:
IgG1, kappa
Molekulargewicht:
150 kDa
Reinheit:
>95%
Versandbedingungen:
Blue Ice
Lagerbedingungen:
2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
Hersteller:
ABclonal Technology
Typ:
Antibody: Biosimilar Antibody
  • Datenblatt des Herstellers:YR0126